Medical Care
Global Drug Delivery in Cancer Market Research Report 2024
- Mar 13, 24
- ID: 121008
- Pages: 105
- Figures: 208
- Views: 28
The global Drug Delivery in Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Drug Delivery in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drug Delivery in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Drug Delivery in Cancer in Hospitals & Clinic is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Drug Delivery in Cancer include Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson and Takeda, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Delivery in Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery in Cancer.
Report Scope
The Drug Delivery in Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Delivery in Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery in Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
Tolmar
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Novartis
Aspen
Shire (Baxalta)
Breckenridge Pharmaceuticals
Galen Pharmaceuticals
Segment by Type
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Segment by Application
Hospitals & Clinic
Cancer Treatment Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery in Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Drug Delivery in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drug Delivery in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Drug Delivery in Cancer in Hospitals & Clinic is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Drug Delivery in Cancer include Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson and Takeda, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Delivery in Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery in Cancer.
Report Scope
The Drug Delivery in Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Delivery in Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery in Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
Tolmar
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Novartis
Aspen
Shire (Baxalta)
Breckenridge Pharmaceuticals
Galen Pharmaceuticals
Segment by Type
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Segment by Application
Hospitals & Clinic
Cancer Treatment Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery in Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Delivery in Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liposomes
1.2.3 PEGylated Proteins & Polypeptides
1.2.4 Polymer Nanoparticle
1.2.5 Protein–drug Conjugates
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug Delivery in Cancer Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Delivery in Cancer Market Perspective (2019-2030)
2.2 Drug Delivery in Cancer Growth Trends by Region
2.2.1 Global Drug Delivery in Cancer Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Delivery in Cancer Historic Market Size by Region (2019-2024)
2.2.3 Drug Delivery in Cancer Forecasted Market Size by Region (2025-2030)
2.3 Drug Delivery in Cancer Market Dynamics
2.3.1 Drug Delivery in Cancer Industry Trends
2.3.2 Drug Delivery in Cancer Market Drivers
2.3.3 Drug Delivery in Cancer Market Challenges
2.3.4 Drug Delivery in Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Delivery in Cancer Players by Revenue
3.1.1 Global Top Drug Delivery in Cancer Players by Revenue (2019-2024)
3.1.2 Global Drug Delivery in Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Drug Delivery in Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Delivery in Cancer Revenue
3.4 Global Drug Delivery in Cancer Market Concentration Ratio
3.4.1 Global Drug Delivery in Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery in Cancer Revenue in 2023
3.5 Drug Delivery in Cancer Key Players Head office and Area Served
3.6 Key Players Drug Delivery in Cancer Product Solution and Service
3.7 Date of Enter into Drug Delivery in Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Delivery in Cancer Breakdown Data by Type
4.1 Global Drug Delivery in Cancer Historic Market Size by Type (2019-2024)
4.2 Global Drug Delivery in Cancer Forecasted Market Size by Type (2025-2030)
5 Drug Delivery in Cancer Breakdown Data by Application
5.1 Global Drug Delivery in Cancer Historic Market Size by Application (2019-2024)
5.2 Global Drug Delivery in Cancer Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Delivery in Cancer Market Size (2019-2030)
6.2 North America Drug Delivery in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Delivery in Cancer Market Size by Country (2019-2024)
6.4 North America Drug Delivery in Cancer Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Delivery in Cancer Market Size (2019-2030)
7.2 Europe Drug Delivery in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Delivery in Cancer Market Size by Country (2019-2024)
7.4 Europe Drug Delivery in Cancer Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery in Cancer Market Size (2019-2030)
8.2 Asia-Pacific Drug Delivery in Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Delivery in Cancer Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Delivery in Cancer Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Delivery in Cancer Market Size (2019-2030)
9.2 Latin America Drug Delivery in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Delivery in Cancer Market Size by Country (2019-2024)
9.4 Latin America Drug Delivery in Cancer Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery in Cancer Market Size (2019-2030)
10.2 Middle East & Africa Drug Delivery in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Delivery in Cancer Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Delivery in Cancer Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Drug Delivery in Cancer Introduction
11.1.4 Amgen Revenue in Drug Delivery in Cancer Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Drug Delivery in Cancer Introduction
11.2.4 Teva Revenue in Drug Delivery in Cancer Business (2019-2024)
11.2.5 Teva Recent Development
11.3 UCB (Union Chimique Belge)
11.3.1 UCB (Union Chimique Belge) Company Detail
11.3.2 UCB (Union Chimique Belge) Business Overview
11.3.3 UCB (Union Chimique Belge) Drug Delivery in Cancer Introduction
11.3.4 UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2019-2024)
11.3.5 UCB (Union Chimique Belge) Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Drug Delivery in Cancer Introduction
11.4.4 Roche Revenue in Drug Delivery in Cancer Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Celgene
11.5.1 Celgene Company Detail
11.5.2 Celgene Business Overview
11.5.3 Celgene Drug Delivery in Cancer Introduction
11.5.4 Celgene Revenue in Drug Delivery in Cancer Business (2019-2024)
11.5.5 Celgene Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Drug Delivery in Cancer Introduction
11.6.4 Sanofi Revenue in Drug Delivery in Cancer Business (2019-2024)
11.6.5 Sanofi Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Drug Delivery in Cancer Introduction
11.7.4 Merck Revenue in Drug Delivery in Cancer Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Drug Delivery in Cancer Introduction
11.8.4 Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2019-2024)
11.8.5 Johnson & Johnson Recent Development
11.9 Takeda
11.9.1 Takeda Company Detail
11.9.2 Takeda Business Overview
11.9.3 Takeda Drug Delivery in Cancer Introduction
11.9.4 Takeda Revenue in Drug Delivery in Cancer Business (2019-2024)
11.9.5 Takeda Recent Development
11.10 Gilead Sciences
11.10.1 Gilead Sciences Company Detail
11.10.2 Gilead Sciences Business Overview
11.10.3 Gilead Sciences Drug Delivery in Cancer Introduction
11.10.4 Gilead Sciences Revenue in Drug Delivery in Cancer Business (2019-2024)
11.10.5 Gilead Sciences Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Drug Delivery in Cancer Introduction
11.11.4 Pfizer Revenue in Drug Delivery in Cancer Business (2019-2024)
11.11.5 Pfizer Recent Development
11.12 Dr Reddy
11.12.1 Dr Reddy Company Detail
11.12.2 Dr Reddy Business Overview
11.12.3 Dr Reddy Drug Delivery in Cancer Introduction
11.12.4 Dr Reddy Revenue in Drug Delivery in Cancer Business (2019-2024)
11.12.5 Dr Reddy Recent Development
11.13 Samyang Biopharmaceuticals
11.13.1 Samyang Biopharmaceuticals Company Detail
11.13.2 Samyang Biopharmaceuticals Business Overview
11.13.3 Samyang Biopharmaceuticals Drug Delivery in Cancer Introduction
11.13.4 Samyang Biopharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024)
11.13.5 Samyang Biopharmaceuticals Recent Development
11.14 Tolmar
11.14.1 Tolmar Company Detail
11.14.2 Tolmar Business Overview
11.14.3 Tolmar Drug Delivery in Cancer Introduction
11.14.4 Tolmar Revenue in Drug Delivery in Cancer Business (2019-2024)
11.14.5 Tolmar Recent Development
11.15 Astellas
11.15.1 Astellas Company Detail
11.15.2 Astellas Business Overview
11.15.3 Astellas Drug Delivery in Cancer Introduction
11.15.4 Astellas Revenue in Drug Delivery in Cancer Business (2019-2024)
11.15.5 Astellas Recent Development
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Detail
11.16.2 AMAG Pharmaceuticals Business Overview
11.16.3 AMAG Pharmaceuticals Drug Delivery in Cancer Introduction
11.16.4 AMAG Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024)
11.16.5 AMAG Pharmaceuticals Recent Development
11.17 AstraZeneca
11.17.1 AstraZeneca Company Detail
11.17.2 AstraZeneca Business Overview
11.17.3 AstraZeneca Drug Delivery in Cancer Introduction
11.17.4 AstraZeneca Revenue in Drug Delivery in Cancer Business (2019-2024)
11.17.5 AstraZeneca Recent Development
11.18 AbbVie
11.18.1 AbbVie Company Detail
11.18.2 AbbVie Business Overview
11.18.3 AbbVie Drug Delivery in Cancer Introduction
11.18.4 AbbVie Revenue in Drug Delivery in Cancer Business (2019-2024)
11.18.5 AbbVie Recent Development
11.19 Novartis
11.19.1 Novartis Company Detail
11.19.2 Novartis Business Overview
11.19.3 Novartis Drug Delivery in Cancer Introduction
11.19.4 Novartis Revenue in Drug Delivery in Cancer Business (2019-2024)
11.19.5 Novartis Recent Development
11.20 Aspen
11.20.1 Aspen Company Detail
11.20.2 Aspen Business Overview
11.20.3 Aspen Drug Delivery in Cancer Introduction
11.20.4 Aspen Revenue in Drug Delivery in Cancer Business (2019-2024)
11.20.5 Aspen Recent Development
11.21 Shire (Baxalta)
11.21.1 Shire (Baxalta) Company Detail
11.21.2 Shire (Baxalta) Business Overview
11.21.3 Shire (Baxalta) Drug Delivery in Cancer Introduction
11.21.4 Shire (Baxalta) Revenue in Drug Delivery in Cancer Business (2019-2024)
11.21.5 Shire (Baxalta) Recent Development
11.22 Breckenridge Pharmaceuticals
11.22.1 Breckenridge Pharmaceuticals Company Detail
11.22.2 Breckenridge Pharmaceuticals Business Overview
11.22.3 Breckenridge Pharmaceuticals Drug Delivery in Cancer Introduction
11.22.4 Breckenridge Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024)
11.22.5 Breckenridge Pharmaceuticals Recent Development
11.23 Galen Pharmaceuticals
11.23.1 Galen Pharmaceuticals Company Detail
11.23.2 Galen Pharmaceuticals Business Overview
11.23.3 Galen Pharmaceuticals Drug Delivery in Cancer Introduction
11.23.4 Galen Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024)
11.23.5 Galen Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Delivery in Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liposomes
1.2.3 PEGylated Proteins & Polypeptides
1.2.4 Polymer Nanoparticle
1.2.5 Protein–drug Conjugates
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug Delivery in Cancer Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Delivery in Cancer Market Perspective (2019-2030)
2.2 Drug Delivery in Cancer Growth Trends by Region
2.2.1 Global Drug Delivery in Cancer Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Delivery in Cancer Historic Market Size by Region (2019-2024)
2.2.3 Drug Delivery in Cancer Forecasted Market Size by Region (2025-2030)
2.3 Drug Delivery in Cancer Market Dynamics
2.3.1 Drug Delivery in Cancer Industry Trends
2.3.2 Drug Delivery in Cancer Market Drivers
2.3.3 Drug Delivery in Cancer Market Challenges
2.3.4 Drug Delivery in Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Delivery in Cancer Players by Revenue
3.1.1 Global Top Drug Delivery in Cancer Players by Revenue (2019-2024)
3.1.2 Global Drug Delivery in Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Drug Delivery in Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Delivery in Cancer Revenue
3.4 Global Drug Delivery in Cancer Market Concentration Ratio
3.4.1 Global Drug Delivery in Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery in Cancer Revenue in 2023
3.5 Drug Delivery in Cancer Key Players Head office and Area Served
3.6 Key Players Drug Delivery in Cancer Product Solution and Service
3.7 Date of Enter into Drug Delivery in Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Delivery in Cancer Breakdown Data by Type
4.1 Global Drug Delivery in Cancer Historic Market Size by Type (2019-2024)
4.2 Global Drug Delivery in Cancer Forecasted Market Size by Type (2025-2030)
5 Drug Delivery in Cancer Breakdown Data by Application
5.1 Global Drug Delivery in Cancer Historic Market Size by Application (2019-2024)
5.2 Global Drug Delivery in Cancer Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Delivery in Cancer Market Size (2019-2030)
6.2 North America Drug Delivery in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Delivery in Cancer Market Size by Country (2019-2024)
6.4 North America Drug Delivery in Cancer Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Delivery in Cancer Market Size (2019-2030)
7.2 Europe Drug Delivery in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Delivery in Cancer Market Size by Country (2019-2024)
7.4 Europe Drug Delivery in Cancer Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery in Cancer Market Size (2019-2030)
8.2 Asia-Pacific Drug Delivery in Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Delivery in Cancer Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Delivery in Cancer Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Delivery in Cancer Market Size (2019-2030)
9.2 Latin America Drug Delivery in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Delivery in Cancer Market Size by Country (2019-2024)
9.4 Latin America Drug Delivery in Cancer Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery in Cancer Market Size (2019-2030)
10.2 Middle East & Africa Drug Delivery in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Delivery in Cancer Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Delivery in Cancer Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Drug Delivery in Cancer Introduction
11.1.4 Amgen Revenue in Drug Delivery in Cancer Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Drug Delivery in Cancer Introduction
11.2.4 Teva Revenue in Drug Delivery in Cancer Business (2019-2024)
11.2.5 Teva Recent Development
11.3 UCB (Union Chimique Belge)
11.3.1 UCB (Union Chimique Belge) Company Detail
11.3.2 UCB (Union Chimique Belge) Business Overview
11.3.3 UCB (Union Chimique Belge) Drug Delivery in Cancer Introduction
11.3.4 UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2019-2024)
11.3.5 UCB (Union Chimique Belge) Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Drug Delivery in Cancer Introduction
11.4.4 Roche Revenue in Drug Delivery in Cancer Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Celgene
11.5.1 Celgene Company Detail
11.5.2 Celgene Business Overview
11.5.3 Celgene Drug Delivery in Cancer Introduction
11.5.4 Celgene Revenue in Drug Delivery in Cancer Business (2019-2024)
11.5.5 Celgene Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Drug Delivery in Cancer Introduction
11.6.4 Sanofi Revenue in Drug Delivery in Cancer Business (2019-2024)
11.6.5 Sanofi Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Drug Delivery in Cancer Introduction
11.7.4 Merck Revenue in Drug Delivery in Cancer Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Drug Delivery in Cancer Introduction
11.8.4 Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2019-2024)
11.8.5 Johnson & Johnson Recent Development
11.9 Takeda
11.9.1 Takeda Company Detail
11.9.2 Takeda Business Overview
11.9.3 Takeda Drug Delivery in Cancer Introduction
11.9.4 Takeda Revenue in Drug Delivery in Cancer Business (2019-2024)
11.9.5 Takeda Recent Development
11.10 Gilead Sciences
11.10.1 Gilead Sciences Company Detail
11.10.2 Gilead Sciences Business Overview
11.10.3 Gilead Sciences Drug Delivery in Cancer Introduction
11.10.4 Gilead Sciences Revenue in Drug Delivery in Cancer Business (2019-2024)
11.10.5 Gilead Sciences Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Drug Delivery in Cancer Introduction
11.11.4 Pfizer Revenue in Drug Delivery in Cancer Business (2019-2024)
11.11.5 Pfizer Recent Development
11.12 Dr Reddy
11.12.1 Dr Reddy Company Detail
11.12.2 Dr Reddy Business Overview
11.12.3 Dr Reddy Drug Delivery in Cancer Introduction
11.12.4 Dr Reddy Revenue in Drug Delivery in Cancer Business (2019-2024)
11.12.5 Dr Reddy Recent Development
11.13 Samyang Biopharmaceuticals
11.13.1 Samyang Biopharmaceuticals Company Detail
11.13.2 Samyang Biopharmaceuticals Business Overview
11.13.3 Samyang Biopharmaceuticals Drug Delivery in Cancer Introduction
11.13.4 Samyang Biopharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024)
11.13.5 Samyang Biopharmaceuticals Recent Development
11.14 Tolmar
11.14.1 Tolmar Company Detail
11.14.2 Tolmar Business Overview
11.14.3 Tolmar Drug Delivery in Cancer Introduction
11.14.4 Tolmar Revenue in Drug Delivery in Cancer Business (2019-2024)
11.14.5 Tolmar Recent Development
11.15 Astellas
11.15.1 Astellas Company Detail
11.15.2 Astellas Business Overview
11.15.3 Astellas Drug Delivery in Cancer Introduction
11.15.4 Astellas Revenue in Drug Delivery in Cancer Business (2019-2024)
11.15.5 Astellas Recent Development
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Detail
11.16.2 AMAG Pharmaceuticals Business Overview
11.16.3 AMAG Pharmaceuticals Drug Delivery in Cancer Introduction
11.16.4 AMAG Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024)
11.16.5 AMAG Pharmaceuticals Recent Development
11.17 AstraZeneca
11.17.1 AstraZeneca Company Detail
11.17.2 AstraZeneca Business Overview
11.17.3 AstraZeneca Drug Delivery in Cancer Introduction
11.17.4 AstraZeneca Revenue in Drug Delivery in Cancer Business (2019-2024)
11.17.5 AstraZeneca Recent Development
11.18 AbbVie
11.18.1 AbbVie Company Detail
11.18.2 AbbVie Business Overview
11.18.3 AbbVie Drug Delivery in Cancer Introduction
11.18.4 AbbVie Revenue in Drug Delivery in Cancer Business (2019-2024)
11.18.5 AbbVie Recent Development
11.19 Novartis
11.19.1 Novartis Company Detail
11.19.2 Novartis Business Overview
11.19.3 Novartis Drug Delivery in Cancer Introduction
11.19.4 Novartis Revenue in Drug Delivery in Cancer Business (2019-2024)
11.19.5 Novartis Recent Development
11.20 Aspen
11.20.1 Aspen Company Detail
11.20.2 Aspen Business Overview
11.20.3 Aspen Drug Delivery in Cancer Introduction
11.20.4 Aspen Revenue in Drug Delivery in Cancer Business (2019-2024)
11.20.5 Aspen Recent Development
11.21 Shire (Baxalta)
11.21.1 Shire (Baxalta) Company Detail
11.21.2 Shire (Baxalta) Business Overview
11.21.3 Shire (Baxalta) Drug Delivery in Cancer Introduction
11.21.4 Shire (Baxalta) Revenue in Drug Delivery in Cancer Business (2019-2024)
11.21.5 Shire (Baxalta) Recent Development
11.22 Breckenridge Pharmaceuticals
11.22.1 Breckenridge Pharmaceuticals Company Detail
11.22.2 Breckenridge Pharmaceuticals Business Overview
11.22.3 Breckenridge Pharmaceuticals Drug Delivery in Cancer Introduction
11.22.4 Breckenridge Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024)
11.22.5 Breckenridge Pharmaceuticals Recent Development
11.23 Galen Pharmaceuticals
11.23.1 Galen Pharmaceuticals Company Detail
11.23.2 Galen Pharmaceuticals Business Overview
11.23.3 Galen Pharmaceuticals Drug Delivery in Cancer Introduction
11.23.4 Galen Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024)
11.23.5 Galen Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Drug Delivery in Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Liposomes
Table 3. Key Players of PEGylated Proteins & Polypeptides
Table 4. Key Players of Polymer Nanoparticle
Table 5. Key Players of Protein–drug Conjugates
Table 6. Key Players of Others
Table 7. Global Drug Delivery in Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Drug Delivery in Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Drug Delivery in Cancer Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Drug Delivery in Cancer Market Share by Region (2019-2024)
Table 11. Global Drug Delivery in Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Drug Delivery in Cancer Market Share by Region (2025-2030)
Table 13. Drug Delivery in Cancer Market Trends
Table 14. Drug Delivery in Cancer Market Drivers
Table 15. Drug Delivery in Cancer Market Challenges
Table 16. Drug Delivery in Cancer Market Restraints
Table 17. Global Drug Delivery in Cancer Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Drug Delivery in Cancer Market Share by Players (2019-2024)
Table 19. Global Top Drug Delivery in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery in Cancer as of 2023)
Table 20. Ranking of Global Top Drug Delivery in Cancer Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Drug Delivery in Cancer Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Drug Delivery in Cancer Product Solution and Service
Table 24. Date of Enter into Drug Delivery in Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drug Delivery in Cancer Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Drug Delivery in Cancer Revenue Market Share by Type (2019-2024)
Table 28. Global Drug Delivery in Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Drug Delivery in Cancer Revenue Market Share by Type (2025-2030)
Table 30. Global Drug Delivery in Cancer Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Drug Delivery in Cancer Revenue Market Share by Application (2019-2024)
Table 32. Global Drug Delivery in Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Drug Delivery in Cancer Revenue Market Share by Application (2025-2030)
Table 34. North America Drug Delivery in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Drug Delivery in Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Drug Delivery in Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Drug Delivery in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Drug Delivery in Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Drug Delivery in Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Drug Delivery in Cancer Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Drug Delivery in Cancer Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Drug Delivery in Cancer Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Drug Delivery in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Drug Delivery in Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Drug Delivery in Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Drug Delivery in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Drug Delivery in Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Drug Delivery in Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 49. Amgen Company Detail
Table 50. Amgen Business Overview
Table 51. Amgen Drug Delivery in Cancer Product
Table 52. Amgen Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. Teva Company Detail
Table 55. Teva Business Overview
Table 56. Teva Drug Delivery in Cancer Product
Table 57. Teva Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 58. Teva Recent Development
Table 59. UCB (Union Chimique Belge) Company Detail
Table 60. UCB (Union Chimique Belge) Business Overview
Table 61. UCB (Union Chimique Belge) Drug Delivery in Cancer Product
Table 62. UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 63. UCB (Union Chimique Belge) Recent Development
Table 64. Roche Company Detail
Table 65. Roche Business Overview
Table 66. Roche Drug Delivery in Cancer Product
Table 67. Roche Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Celgene Company Detail
Table 70. Celgene Business Overview
Table 71. Celgene Drug Delivery in Cancer Product
Table 72. Celgene Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 73. Celgene Recent Development
Table 74. Sanofi Company Detail
Table 75. Sanofi Business Overview
Table 76. Sanofi Drug Delivery in Cancer Product
Table 77. Sanofi Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Merck Company Detail
Table 80. Merck Business Overview
Table 81. Merck Drug Delivery in Cancer Product
Table 82. Merck Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Johnson & Johnson Company Detail
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Drug Delivery in Cancer Product
Table 87. Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. Takeda Company Detail
Table 90. Takeda Business Overview
Table 91. Takeda Drug Delivery in Cancer Product
Table 92. Takeda Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 93. Takeda Recent Development
Table 94. Gilead Sciences Company Detail
Table 95. Gilead Sciences Business Overview
Table 96. Gilead Sciences Drug Delivery in Cancer Product
Table 97. Gilead Sciences Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 98. Gilead Sciences Recent Development
Table 99. Pfizer Company Detail
Table 100. Pfizer Business Overview
Table 101. Pfizer Drug Delivery in Cancer Product
Table 102. Pfizer Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 103. Pfizer Recent Development
Table 104. Dr Reddy Company Detail
Table 105. Dr Reddy Business Overview
Table 106. Dr Reddy Drug Delivery in Cancer Product
Table 107. Dr Reddy Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 108. Dr Reddy Recent Development
Table 109. Samyang Biopharmaceuticals Company Detail
Table 110. Samyang Biopharmaceuticals Business Overview
Table 111. Samyang Biopharmaceuticals Drug Delivery in Cancer Product
Table 112. Samyang Biopharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 113. Samyang Biopharmaceuticals Recent Development
Table 114. Tolmar Company Detail
Table 115. Tolmar Business Overview
Table 116. Tolmar Drug Delivery in Cancer Product
Table 117. Tolmar Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 118. Tolmar Recent Development
Table 119. Astellas Company Detail
Table 120. Astellas Business Overview
Table 121. Astellas Drug Delivery in Cancer Product
Table 122. Astellas Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 123. Astellas Recent Development
Table 124. AMAG Pharmaceuticals Company Detail
Table 125. AMAG Pharmaceuticals Business Overview
Table 126. AMAG Pharmaceuticals Drug Delivery in Cancer Product
Table 127. AMAG Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 128. AMAG Pharmaceuticals Recent Development
Table 129. AstraZeneca Company Detail
Table 130. AstraZeneca Business Overview
Table 131. AstraZeneca Drug Delivery in Cancer Product
Table 132. AstraZeneca Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 133. AstraZeneca Recent Development
Table 134. AbbVie Company Detail
Table 135. AbbVie Business Overview
Table 136. AbbVie Drug Delivery in Cancer Product
Table 137. AbbVie Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 138. AbbVie Recent Development
Table 139. Novartis Company Detail
Table 140. Novartis Business Overview
Table 141. Novartis Drug Delivery in Cancer Product
Table 142. Novartis Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 143. Novartis Recent Development
Table 144. Aspen Company Detail
Table 145. Aspen Business Overview
Table 146. Aspen Drug Delivery in Cancer Product
Table 147. Aspen Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 148. Aspen Recent Development
Table 149. Shire (Baxalta) Company Detail
Table 150. Shire (Baxalta) Business Overview
Table 151. Shire (Baxalta) Drug Delivery in Cancer Product
Table 152. Shire (Baxalta) Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 153. Shire (Baxalta) Recent Development
Table 154. Breckenridge Pharmaceuticals Company Detail
Table 155. Breckenridge Pharmaceuticals Business Overview
Table 156. Breckenridge Pharmaceuticals Drug Delivery in Cancer Product
Table 157. Breckenridge Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 158. Breckenridge Pharmaceuticals Recent Development
Table 159. Galen Pharmaceuticals Company Detail
Table 160. Galen Pharmaceuticals Business Overview
Table 161. Galen Pharmaceuticals Drug Delivery in Cancer Product
Table 162. Galen Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 163. Galen Pharmaceuticals Recent Development
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Delivery in Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Drug Delivery in Cancer Market Share by Type: 2023 VS 2030
Figure 3. Liposomes Features
Figure 4. PEGylated Proteins & Polypeptides Features
Figure 5. Polymer Nanoparticle Features
Figure 6. Protein–drug Conjugates Features
Figure 7. Others Features
Figure 8. Global Drug Delivery in Cancer Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Drug Delivery in Cancer Market Share by Application: 2023 VS 2030
Figure 10. Hospitals & Clinic Case Studies
Figure 11. Cancer Treatment Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Drug Delivery in Cancer Report Years Considered
Figure 14. Global Drug Delivery in Cancer Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Drug Delivery in Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Drug Delivery in Cancer Market Share by Region: 2023 VS 2030
Figure 17. Global Drug Delivery in Cancer Market Share by Players in 2023
Figure 18. Global Top Drug Delivery in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery in Cancer as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Drug Delivery in Cancer Revenue in 2023
Figure 20. North America Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Drug Delivery in Cancer Market Share by Country (2019-2030)
Figure 22. United States Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Drug Delivery in Cancer Market Share by Country (2019-2030)
Figure 26. Germany Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Drug Delivery in Cancer Market Share by Region (2019-2030)
Figure 34. China Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Drug Delivery in Cancer Market Share by Country (2019-2030)
Figure 42. Mexico Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Drug Delivery in Cancer Market Share by Country (2019-2030)
Figure 46. Turkey Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Amgen Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 49. Teva Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 50. UCB (Union Chimique Belge) Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 52. Celgene Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 53. Sanofi Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 54. Merck Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 55. Johnson & Johnson Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 56. Takeda Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 57. Gilead Sciences Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 58. Pfizer Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 59. Dr Reddy Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 60. Samyang Biopharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 61. Tolmar Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 62. Astellas Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 63. AMAG Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 64. AstraZeneca Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 65. AbbVie Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 66. Novartis Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 67. Aspen Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 68. Shire (Baxalta) Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 69. Breckenridge Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 70. Galen Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Table 1. Global Drug Delivery in Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Liposomes
Table 3. Key Players of PEGylated Proteins & Polypeptides
Table 4. Key Players of Polymer Nanoparticle
Table 5. Key Players of Protein–drug Conjugates
Table 6. Key Players of Others
Table 7. Global Drug Delivery in Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Drug Delivery in Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Drug Delivery in Cancer Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Drug Delivery in Cancer Market Share by Region (2019-2024)
Table 11. Global Drug Delivery in Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Drug Delivery in Cancer Market Share by Region (2025-2030)
Table 13. Drug Delivery in Cancer Market Trends
Table 14. Drug Delivery in Cancer Market Drivers
Table 15. Drug Delivery in Cancer Market Challenges
Table 16. Drug Delivery in Cancer Market Restraints
Table 17. Global Drug Delivery in Cancer Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Drug Delivery in Cancer Market Share by Players (2019-2024)
Table 19. Global Top Drug Delivery in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery in Cancer as of 2023)
Table 20. Ranking of Global Top Drug Delivery in Cancer Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Drug Delivery in Cancer Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Drug Delivery in Cancer Product Solution and Service
Table 24. Date of Enter into Drug Delivery in Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drug Delivery in Cancer Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Drug Delivery in Cancer Revenue Market Share by Type (2019-2024)
Table 28. Global Drug Delivery in Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Drug Delivery in Cancer Revenue Market Share by Type (2025-2030)
Table 30. Global Drug Delivery in Cancer Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Drug Delivery in Cancer Revenue Market Share by Application (2019-2024)
Table 32. Global Drug Delivery in Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Drug Delivery in Cancer Revenue Market Share by Application (2025-2030)
Table 34. North America Drug Delivery in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Drug Delivery in Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Drug Delivery in Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Drug Delivery in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Drug Delivery in Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Drug Delivery in Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Drug Delivery in Cancer Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Drug Delivery in Cancer Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Drug Delivery in Cancer Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Drug Delivery in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Drug Delivery in Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Drug Delivery in Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Drug Delivery in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Drug Delivery in Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Drug Delivery in Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 49. Amgen Company Detail
Table 50. Amgen Business Overview
Table 51. Amgen Drug Delivery in Cancer Product
Table 52. Amgen Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. Teva Company Detail
Table 55. Teva Business Overview
Table 56. Teva Drug Delivery in Cancer Product
Table 57. Teva Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 58. Teva Recent Development
Table 59. UCB (Union Chimique Belge) Company Detail
Table 60. UCB (Union Chimique Belge) Business Overview
Table 61. UCB (Union Chimique Belge) Drug Delivery in Cancer Product
Table 62. UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 63. UCB (Union Chimique Belge) Recent Development
Table 64. Roche Company Detail
Table 65. Roche Business Overview
Table 66. Roche Drug Delivery in Cancer Product
Table 67. Roche Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Celgene Company Detail
Table 70. Celgene Business Overview
Table 71. Celgene Drug Delivery in Cancer Product
Table 72. Celgene Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 73. Celgene Recent Development
Table 74. Sanofi Company Detail
Table 75. Sanofi Business Overview
Table 76. Sanofi Drug Delivery in Cancer Product
Table 77. Sanofi Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Merck Company Detail
Table 80. Merck Business Overview
Table 81. Merck Drug Delivery in Cancer Product
Table 82. Merck Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Johnson & Johnson Company Detail
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Drug Delivery in Cancer Product
Table 87. Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. Takeda Company Detail
Table 90. Takeda Business Overview
Table 91. Takeda Drug Delivery in Cancer Product
Table 92. Takeda Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 93. Takeda Recent Development
Table 94. Gilead Sciences Company Detail
Table 95. Gilead Sciences Business Overview
Table 96. Gilead Sciences Drug Delivery in Cancer Product
Table 97. Gilead Sciences Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 98. Gilead Sciences Recent Development
Table 99. Pfizer Company Detail
Table 100. Pfizer Business Overview
Table 101. Pfizer Drug Delivery in Cancer Product
Table 102. Pfizer Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 103. Pfizer Recent Development
Table 104. Dr Reddy Company Detail
Table 105. Dr Reddy Business Overview
Table 106. Dr Reddy Drug Delivery in Cancer Product
Table 107. Dr Reddy Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 108. Dr Reddy Recent Development
Table 109. Samyang Biopharmaceuticals Company Detail
Table 110. Samyang Biopharmaceuticals Business Overview
Table 111. Samyang Biopharmaceuticals Drug Delivery in Cancer Product
Table 112. Samyang Biopharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 113. Samyang Biopharmaceuticals Recent Development
Table 114. Tolmar Company Detail
Table 115. Tolmar Business Overview
Table 116. Tolmar Drug Delivery in Cancer Product
Table 117. Tolmar Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 118. Tolmar Recent Development
Table 119. Astellas Company Detail
Table 120. Astellas Business Overview
Table 121. Astellas Drug Delivery in Cancer Product
Table 122. Astellas Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 123. Astellas Recent Development
Table 124. AMAG Pharmaceuticals Company Detail
Table 125. AMAG Pharmaceuticals Business Overview
Table 126. AMAG Pharmaceuticals Drug Delivery in Cancer Product
Table 127. AMAG Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 128. AMAG Pharmaceuticals Recent Development
Table 129. AstraZeneca Company Detail
Table 130. AstraZeneca Business Overview
Table 131. AstraZeneca Drug Delivery in Cancer Product
Table 132. AstraZeneca Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 133. AstraZeneca Recent Development
Table 134. AbbVie Company Detail
Table 135. AbbVie Business Overview
Table 136. AbbVie Drug Delivery in Cancer Product
Table 137. AbbVie Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 138. AbbVie Recent Development
Table 139. Novartis Company Detail
Table 140. Novartis Business Overview
Table 141. Novartis Drug Delivery in Cancer Product
Table 142. Novartis Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 143. Novartis Recent Development
Table 144. Aspen Company Detail
Table 145. Aspen Business Overview
Table 146. Aspen Drug Delivery in Cancer Product
Table 147. Aspen Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 148. Aspen Recent Development
Table 149. Shire (Baxalta) Company Detail
Table 150. Shire (Baxalta) Business Overview
Table 151. Shire (Baxalta) Drug Delivery in Cancer Product
Table 152. Shire (Baxalta) Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 153. Shire (Baxalta) Recent Development
Table 154. Breckenridge Pharmaceuticals Company Detail
Table 155. Breckenridge Pharmaceuticals Business Overview
Table 156. Breckenridge Pharmaceuticals Drug Delivery in Cancer Product
Table 157. Breckenridge Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 158. Breckenridge Pharmaceuticals Recent Development
Table 159. Galen Pharmaceuticals Company Detail
Table 160. Galen Pharmaceuticals Business Overview
Table 161. Galen Pharmaceuticals Drug Delivery in Cancer Product
Table 162. Galen Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)
Table 163. Galen Pharmaceuticals Recent Development
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Delivery in Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Drug Delivery in Cancer Market Share by Type: 2023 VS 2030
Figure 3. Liposomes Features
Figure 4. PEGylated Proteins & Polypeptides Features
Figure 5. Polymer Nanoparticle Features
Figure 6. Protein–drug Conjugates Features
Figure 7. Others Features
Figure 8. Global Drug Delivery in Cancer Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Drug Delivery in Cancer Market Share by Application: 2023 VS 2030
Figure 10. Hospitals & Clinic Case Studies
Figure 11. Cancer Treatment Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Drug Delivery in Cancer Report Years Considered
Figure 14. Global Drug Delivery in Cancer Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Drug Delivery in Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Drug Delivery in Cancer Market Share by Region: 2023 VS 2030
Figure 17. Global Drug Delivery in Cancer Market Share by Players in 2023
Figure 18. Global Top Drug Delivery in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery in Cancer as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Drug Delivery in Cancer Revenue in 2023
Figure 20. North America Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Drug Delivery in Cancer Market Share by Country (2019-2030)
Figure 22. United States Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Drug Delivery in Cancer Market Share by Country (2019-2030)
Figure 26. Germany Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Drug Delivery in Cancer Market Share by Region (2019-2030)
Figure 34. China Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Drug Delivery in Cancer Market Share by Country (2019-2030)
Figure 42. Mexico Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Drug Delivery in Cancer Market Share by Country (2019-2030)
Figure 46. Turkey Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Amgen Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 49. Teva Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 50. UCB (Union Chimique Belge) Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 52. Celgene Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 53. Sanofi Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 54. Merck Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 55. Johnson & Johnson Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 56. Takeda Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 57. Gilead Sciences Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 58. Pfizer Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 59. Dr Reddy Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 60. Samyang Biopharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 61. Tolmar Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 62. Astellas Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 63. AMAG Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 64. AstraZeneca Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 65. AbbVie Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 66. Novartis Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 67. Aspen Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 68. Shire (Baxalta) Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 69. Breckenridge Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 70. Galen Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Paint Leveling Agent Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Adhesion Promoters Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Rheological Additives Market Insights, Forecast to 2030
Dec 22, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232